MENU
CRNX
Stock ticker:
PRICE
CHANGE
CAPITALIZATION

Crinetics Pharmaceuticals (CRNX) Earnings Date & Reports

A.I. Advisor
published Earnings

CRNX is expected to report earnings to fall 3.12% to -91 cents per share on November 12

Crinetics Pharmaceuticals CRNX Stock Earnings Reports
Q3'24
Est.
$-0.91
Q2'24
Missed
by $0.08
Q1'24
Missed
by $0.13
Q4'23
Missed
by $0.04
Q3'23
Missed
by $0.14
The last earnings report on August 08 showed earnings per share of -93 cents, missing the estimate of -86 cents. With 462.29K shares outstanding, the current market capitalization sits at 4.09B.
View a ticker or compare two or three
CRNX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of therapeutics for endocrine-related diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
6055 Lusk Boulevard
Phone
+1 858 450-6464
Employees
290
Web
https://www.crinetics.com